COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma.

نویسندگان

  • A Papi
  • G Casoni
  • G Caramori
  • I Guzzinati
  • P Boschetto
  • F Ravenna
  • N Calia
  • S Petruzzelli
  • L Corbetta
  • G Cavallesco
  • E Forini
  • M Saetta
  • A Ciaccia
  • L M Fabbri
چکیده

BACKGROUND Squamous cell carcinoma has a stronger association with tobacco smoking than other non-small cell lung cancers (NSCLC). A study was undertaken to determine whether chronic obstructive pulmonary disease (COPD) is a risk factor for the squamous cell carcinoma histological subtype in smokers with surgically resectable NSCLC. METHODS Using a case-control design, subjects with a surgically confirmed diagnosis of squamous cell carcinoma were enrolled from smokers undergoing lung resection for NSCLC in the District Hospital of Ferrara, Italy. Control subjects were smokers who underwent lung resection for NSCLC in the same hospital and had a surgically confirmed diagnosis of NSCLC of any histological type other than squamous cell. RESULTS Eighty six cases and 54 controls (mainly adenocarcinoma, n = 50) were enrolled. The presence of COPD was found to increase the risk for the squamous cell histological subtype by more than four times. Conversely, the presence of chronic bronchitis was found to decrease the risk for this histological subtype by more than four times. Among patients with chronic bronchitis (n = 77), those with COPD had a 3.5 times higher risk of having the squamous cell histological subtype. CONCLUSIONS These data suggest that, among smokers with surgically resectable NSCLC, COPD is a risk factor for the squamous cell histological subtype and chronic bronchitis, particularly when not associated with COPD, is a risk factor for the adenocarcinoma histological subtype.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

CHRONIC OBSTRUCTIVE PULMONARY DISEASE COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma

A Papi, G Casoni, G Caramori, I Guzzinati, P Boschetto, F Ravenna, N Calia, S Petruzzelli, L Corbetta, G Cavallesco, E Forini, M Saetta, A Ciaccia, L M Fabbri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...

متن کامل

A Case Report of Small Cell Lung Carcinoma in a Patient with Progressive Diffuse Sclerosis

 Connective tissue diseases, including scleroderma, may be associated with an increased risk of lung cancer. The most common type of lung cancer associated with systemic sclerosis is adenocarcinoma or bronchoalveolar carcinoma, and small cell carcinoma is rare. This reports presents a 54-year-old non-smoker woman with a history of scleroderma who was examined due to aggravation of shortness of ...

متن کامل

The Assessment of Serum Apelin-12 Level in a Variety of Pulmonary Malignancies in Smokers

Background: Apelin has recently been considered as an adipokine secreted from visceral fat. Apelin and itsreceptor exist in many tissues including lung and play significant roles in many physiological andpathological activities. However, serum level of apelin-12 is unknown in smokers and in various types of lungmalignancies. There...

متن کامل

Molecular and Cellular Pathobiology Modulation of Cystatin A Expression in Human Airway Epithelium Related to Genotype, Smoking, COPD, and Lung Cancer

The cathepsin inhibitor Cystatin A (CSTA) has antiapoptotic properties linked with neoplastic changes in squamous cell epithelium, where it has been proposed as a diagnostic and prognostic marker of lung cancer. Notably, cystatin A is upregulated in dysplastic epithelium, prompting us to hypothesize that it might be modulated in chronic obstructive pulmonary disease (COPD), a small airway epith...

متن کامل

Modulation of cystatin A expression in human airway epithelium related to genotype, smoking, COPD, and lung cancer.

The cathepsin inhibitor Cystatin A (CSTA) has antiapoptotic properties linked with neoplastic changes in squamous cell epithelium, where it has been proposed as a diagnostic and prognostic marker of lung cancer. Notably, cystatin A is upregulated in dysplastic epithelium, prompting us to hypothesize that it might be modulated in chronic obstructive pulmonary disease (COPD), a small airway epith...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Thorax

دوره 59 8  شماره 

صفحات  -

تاریخ انتشار 2004